3 Stocks Including Omada Health That May Be Priced Below Estimated Intrinsic Value
The United States market has shown robust performance recently, with a 2.2% increase over the last week and a 21% climb in the past year, alongside an expected annual earnings growth of 17%. In such an environment, identifying stocks that are potentially undervalued relative to their intrinsic value can offer opportunities for investors seeking to capitalize on favorable market conditions.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Zeta Global Holdings (ZETA) | $27.54 | $52.60 | 47.6% |
| Workday (WDAY) | $184.19 | $343.15 | 46.3% |
| Symbotic (SYM) | $40.11 | $79.63 | 49.6% |
| Sandisk (SNDK) | $1237.92 | $1238.02 | 0% |
| MercadoLibre (MELI) | $1824.34 | $3476.75 | 47.5% |
| Luckin Coffee (LKNC.Y) | $33.50 | $64.14 | 47.8% |
| Jacobs Solutions (J) | $147.33 | $276.46 | 46.7% |
| Hims & Hers Health (HIMS) | $31.77 | $61.95 | 48.7% |
| HawkEye 360 (HAWK) | $25.19 | $48.02 | 47.5% |
| Alerus Financial (ALRS) | $33.21 | $63.34 | 47.6% |
Let's dive into some prime choices out of the screener.
Omada Health (OMDA)
Overview: Omada Health, Inc., along with its subsidiary Physera, Inc., offers virtual care programs in the United States and has a market cap of $1.45 billion.
Operations: Omada Health, Inc., through its subsidiary Physera, Inc., generates revenue by providing a variety of virtual care programs across the United States.
Estimated Discount To Fair Value: 30.9%
Omada Health, Inc. is trading at US$24.99, significantly below its estimated future cash flow value of US$36.16, indicating potential undervaluation based on cash flows. The company has turned profitable with a net income of US$5.29 million in Q2 2026 and expects earnings to grow substantially at 69.7% annually, outpacing the broader market's growth rate. However, recent insider selling and low forecasted return on equity highlight some risks for investors to consider.
- According our earnings growth report, there's an indication that Omada Health might be ready to expand.
- Click here to discover the nuances of Omada Health with our detailed financial health report.
LandBridge (LB)
Overview: LandBridge Company LLC, along with its subsidiaries, focuses on owning and managing land and resources to facilitate oil and natural gas development in the United States, with a market cap of $5.81 billion.
Operations: LandBridge generates revenue from owning and managing land and resources to support oil and natural gas development in the United States.
Estimated Discount To Fair Value: 31%
LandBridge Company LLC is trading at US$81.71, well below its estimated future cash flow value of US$118.35, highlighting potential undervaluation. The firm reported Q2 2026 earnings with revenue of US$66.84 million and net income of US$12.29 million, showing growth from the previous year. Although profit margins have decreased to 16.2%, the company forecasts significant annual earnings growth of 59.22%. Despite high debt levels, LandBridge is actively pursuing strategic acquisitions to bolster its position further.
- Insights from our recent growth report point to a promising forecast for LandBridge's business outlook.
- Get an in-depth perspective on LandBridge's balance sheet by reading our health report here.
On Holding (ONON)
Overview: On Holding AG, with a market cap of $12.43 billion, develops and distributes performance sports products under the On brand across Switzerland, Europe, the Middle East, Africa, the United States, the Americas, and Asia-Pacific.
Operations: The company's revenue segment for Athletic Footwear amounts to CHF 3.12 billion.
Estimated Discount To Fair Value: 29.9%
On Holding, trading at US$38.78, is significantly undervalued compared to its estimated future cash flow value of US$55.33. The company forecasts strong earnings growth of 23.2% annually over the next three years, outpacing the broader market's growth rate. Recent strategic advancements include scaling up production of its eco-friendly Cloud X 5 shoes using captured carbon technology, which aligns with On's sustainable innovation goals and could enhance long-term profitability and market positioning.
- The growth report we've compiled suggests that On Holding's future prospects could be on the up.
- Delve into the full analysis health report here for a deeper understanding of On Holding.
Seize The Opportunity
- Reveal the 132 hidden gems among our Undervalued US Stocks Based On Cash Flows screener with a single click here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com